Theramir’s proprietary technologies are based on microRNAs (miRNAs), a class of small non-coding RNAs that can regulate multiple genes and pathways associated with cancer growth and metastasis. The company has developed a panel of miRNAs, both biological and synthetic, which can affect the function and disrupt expression of an expanding list of oncoproteins that are dysregulated in most cancer types. Thus, our technologies can be applied to the development of novel targeted therapeutics that may potentially transform the precision oncology field by creating new knowledge on the pathology of the disease and by enabling the customization and personalization of cancer treatment.
View Top Employees from Theramir LtdWebsite | http://www.theramir.com |
Revenue | $6.1 million |
Employees | 9 (2 on RocketReach) |
Founded | 2016 |
Address | 13 Georgiou Karaiskaki, Limassol, Limassol, CY |
Phone | +357 99 372914 |
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Theramir Ltd employee's phone or email?
The Theramir Ltd annual revenue was $6.1 million in 2024.
2 people are employed at Theramir Ltd.
Theramir Ltd is based in Limassol, Limassol.
The NAICS codes for Theramir Ltd are [541, 5417, 54171, 54, 541713].
The SIC codes for Theramir Ltd are [873, 87].